2013 Annual Meeting | Pseudotumor Cerebri

Date Wednesday 04/30/14

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Victoria S. Pelak, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to recognize the common clinical manifestations of pseudotumor cerebri; select the appropriate laboratory, neuroimaging, ophthalmic, and other studies needed to diagnose and follow patients with this disorder; list commonly encountered secondary causes of pseudotumor cerebri; understand the indications, benefits, and limitations of currently used medical, interventional, and surgical treatments; and identify challenges in the diagnosis and treatment of pseudotumor cerebri.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience General Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
06:30 AM - 06:50 AM		Pseudotumor Cerebri Basics Victoria S. Pelak, MD, FAAN
06:50 AM - 07:05 AM		Visual Fields in Peudotumor Cerebri Victoria S. Pelak, MD, FAAN
07:05 AM - 07:30 AM		Treatment of Pseudotumor Cerebri: Part I Deborah I. Friedman, MD, MPH, FAAN
07:30 AM - 07:40 AM		Break
07:40 AM - 07:55 AM		Treatment of Pseudotumor Cerebri: Part II Deborah I. Friedman, MD, MPH, FAAN
07:55 AM - 08:15 AM		Case Presentations Deborah I. Friedman, MD, MPH, FAAN, Victoria S. Pelak, MD, FAAN
08:15 AM - 08:30 AM		Questions and Answers Deborah I. Friedman, MD, MPH, FAAN, Victoria S. Pelak, MD, FAAN

Faculty Disclosures
Deborah I. Friedman, MD, MPH, FAAN	Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Satsuma. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . The institution of Dr. Friedman has received research support from Spinal CSF Leak Foundation. Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Treasurer, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Victoria S. Pelak, MD, FAAN	Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Pelak has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-ophthalmology Society. Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Pelak has received research support from Biogen. Dr. Pelak has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��